CrystalGenomics Inc (083790) — Financial Flexibility Index
CrystalGenomics Inc (083790) has a Financial Flexibility Index of -0.09x as of September 2025. Free cash flow of ₩-10.76 Billion (operating CF ₩-11.39 Billion minus capex ₩627.69 Million) represents 0% of total liabilities (₩124.24 Billion). Check 083790 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
CrystalGenomics Inc Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for CrystalGenomics Inc across 11 annual periods. For the full cash flow conversion analysis, see CrystalGenomics Inc cash conversion from operations.
Annual Financial Flexibility Index for CrystalGenomics Inc (2014–2024)
Year-by-year free cash flow to debt coverage for CrystalGenomics Inc. Explore how well can CrystalGenomics Inc service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.10x | ₩-15.91 Billion | ₩-25.85 Billion | ₩161.95 Billion | ▼ -8.6% |
| 2023 | -0.09x | ₩-8.85 Billion | ₩-32.41 Billion | ₩97.82 Billion | ▼ -24.9% |
| 2022 | -0.07x | ₩-9.73 Billion | ₩-24.40 Billion | ₩134.34 Billion | ▼ -963.7% |
| 2021 | -0.01x | ₩-851.42 Million | ₩-11.46 Billion | ₩125.09 Billion | ▲ +92.8% |
| 2020 | -0.09x | ₩-9.64 Billion | ₩-16.38 Billion | ₩102.20 Billion | ▼ -232.9% |
| 2019 | -0.03x | ₩-6.52 Billion | ₩-7.14 Billion | ₩230.14 Billion | ▼ -124.7% |
| 2018 | -0.01x | ₩-913.29 Million | ₩-1.21 Billion | ₩72.45 Billion | ▼ -102.8% |
| 2017 | 0.44x | ₩12.37 Billion | ₩1.63 Billion | ₩27.88 Billion | ▲ +365.7% |
| 2016 | -0.17x | ₩-7.60 Billion | ₩-8.30 Billion | ₩45.51 Billion | ▼ -115.6% |
| 2015 | -0.08x | ₩-4.29 Billion | ₩-4.73 Billion | ₩55.34 Billion | ▼ -9.6% |
| 2014 | -0.07x | ₩-3.60 Billion | ₩-3.75 Billion | ₩51.02 Billion | — |